Skip to content

NIH K99/R00: 19.5% Success Rate, 2027 Due Dates, PA-24-194

Updated 15 official sources

Quick Answer: The K99/R00 success rate was 19.5% in FY2025, 319 awards from 1,632 reviewed applications, down from 25.0% in FY2024, according to NIH Data Book table 204 (checked November 15, 2026; FY2026 isn't published yet).

Full answer and how we checked it

The next parent K99 deadlines are February 12, 2027 for new applications and March 12, 2027 for resubmissions under PA-24-194 (opens in a new tab), the last dates before it expires May 8, 2027, while NCI's own K99 (PAR-25-135) is next due February 17, 2027. Institute rates ranged from 6.1% at NIMH to 32.3% at NIAID among institutes that reviewed 90 or more applications, so check your target institute's row before you plan around the average. The parent route has no citizenship requirement, but temporary visa holders need phase-specific documentation. Under NIH notice NOT-OD-26-098, the K99 becomes part of a new KT1/R00 award for due dates on or after October 12, 2027.

This guide is for: postdocs deciding whether and when to apply for the K99/R00, and research administrators checking the success rate and next due date.

Data note: Award amounts reflect current NIH program announcements (PA-24-194 for the parent program and PAR-25-135 for NCI's standalone program). NIH-wide and institute success rates come from NIH Data Book table 204 (career development grants by activity code and institute, FY2015 to FY2025), which Grantsights downloaded from report.nih.gov on October 8, 2026 and again on November 15, 2026, when FY2025 was still the latest year. NCI's own workshop chart and its FY2007 to FY2022 evaluation are shown separately because they count a different application set. FY2026 rates aren't published yet.

In this guide
K99/R00 route questionFirst source to openWhat to verify before writing
No independent clinical trialParent K99/R00 clinical trial not allowedPA-24-194, 4-year postdoc clock, IC participation, mentor plan
Candidate will lead an independent clinical trialParent K99/R00 clinical trial requiredPA-24-193, trial leadership, human-subjects plan; NOT-OD-26-098 ends trial-required K NOFOs, and current K NOFOs expire by July 13, 2027
Prospective basic study with human participantsParent K99/R00 basic experimental studiesPA-24-195, BESH fit, enrollment and methods
Cancer researchNCI K99/R00 standalone routeNCI notice, 6-year window if applicable, mentor-overlap policy
Vision research with a DP2-style early-investigator pathNEI New Innovator DP2 pagePAR-26-087 forecast state, no-trial status, NEI fit, final-route check
Already independent or too close to faculty launchK01, K08, K23, R21, R01, or institute-specific K routeWhether the K99 mentored phase is still credible

The K99/R00 Pathway to Independence Award is NIH's mechanism for converting high-potential postdoctoral researchers into independent faculty investigators. A 2024 eLife analysis counted 3,456 extramural K99 awards from 2006 through 2021 and found that 2,701 of those awardees, 78%, went on to activate the R00 phase.

But the program has real structural inequities and practical traps that most guides don't address. The same eLife analysis found that 54% of K99 awardees were at just 10% of institutions, and that no K99 awardee had yet been at a Historically Black College or University. And NCI's January 2025 exit from the parent program created confusion for cancer researchers about where and how to apply.

This guide gives you what the official program announcements don't: current NCI requirements, the career outcome data, institute-by-institute differences, and an honest assessment of when the K99 is the right strategy versus when you should skip it.

From Manusights, our sister product

Planning a K award? Manusights offers an AI critique of your application against NIH's published review criteria: $149 for a K99 or any other K award. Back within 3 business days of your upload.

Order a grant review

What Is the K99/R00 Success Rate?

NIH funded 19.5% of reviewed K99 applications in FY2025, the lowest rate in NIH Data Book table 204, which starts in FY2015. According to table 204, applications reached 1,632, the most in any year since FY2015, while awards fell to 319, so the rate dropped 5.4 points in one year after holding between 24.0% and 26.0% from FY2019 to FY2024. Grantsights analysis of the same table shows first-year K99 funding fell from $51.4M in FY2023 to $42.3M in FY2025.

Fiscal yearApplications reviewedAwardsSuccess rateTotal funding
FY201593220822.3%$22.8M
FY20161,00423123.0%$26.6M
FY20171,00523523.4%$27.3M
FY20181,02226826.2%$30.2M
FY20191,08326024.0%$29.9M
FY20201,18929925.1%$35.1M
FY20211,41834924.6%$41.0M
FY20221,55138524.8%$45.9M
FY20231,58641226.0%$51.4M
FY20241,43835925.0%$46.1M
FY20251,63231919.5%$42.3M

The average hides a wide spread by institute. Among institutes that reviewed at least 25 K99 applications in FY2025, rates ran from 6.1% at NIMH and 7.8% at NIA to 32.3% at NIAID and 31.0% at NIBIB. A red flag for planning: NIA and NIMH together reviewed 277 applications and funded 20, so an aging or mental-health postdoc shouldn't assume the NIH-wide 19.5%.

Institute (FY2025)Applications reviewedAwardsSuccess rate
NCI3346419.2%
NIA179147.8%
NINDS1462718.5%
NIGMS1402316.4%
NHLBI1394028.8%
NIMH9866.1%
NIAID933032.3%
NICHD902022.2%
NIDDK651421.5%
NIDA491020.4%
NEI461430.4%
NIEHS431227.9%
NIAMS39512.8%
NIDCR33618.2%
NIAAA31929.0%
NIBIB29931.0%
NHGRI25728.0%

Grantsights analysis of the 11 years in table 204 shows why the rate fell: reviewed applications rose 75%, from 932 in FY2015 to 1,632 in FY2025, while awards rose 53%, from 208 to 319, and the FY2025 drop came from awards falling as applications climbed.

Small institutes swing a lot from year to year: with 30 to 50 applications, a handful of awards moves the rate by 10 points. Treat one year's row as context, not a forecast. Institutes with fewer than 25 reviewed applications are left out of this table but appear in table 204 (opens in a new tab).

NCI's own numbers don't match its Data Book row. Table 204 counts 334 reviewed applications and 64 awards for NCI in FY2025 (19.2%), while NCI's March 2026 career-development workshop chart shows about 220 applications and 38 awards (17.5%). Grantsights couldn't find a published reconciliation; NCI's chart may count a narrower set of applications. Keep the two sources separate:

NCI evidence unitApplications and awardsReported rateWhat the number can tell you
NIH Data Book, NCI row, FY2025334 reviewed, 64 awarded19.2%NCI on the same basis as every other institute in table 204
NCI workshop chart, FY2025About 220 applications and 38 awards17.5%NCI's own count for its K99 routes
NCI workshop chart, FY2024About 188 applications and 23 awards12.5%One NCI fiscal year, not a forecast
NCI FY2007-FY2022 evaluation2,764 applications and 512 awards20.8% averageA 16-year NCI benchmark with a 12.3% to 32.1% annual range
NCI workshop chart, FY2026About 292 applications; awards not finalNot reportedDemand for the new NCI PARs, not a success-rate result

The decision rule is simple: start from your target institute's FY2025 row in table 204, then keep new applications, resubmissions, awards, and K99-to-R00 transitions separate. An applicant targeting NIDDK (21.5%), NIGMS (16.4%), or NINDS (18.5%) should still ask the program officer how the institute is funding K99s in FY2026, because table 204 only runs through FY2025. The NCI K99/R00 page (opens in a new tab) owns NCI eligibility and application policy; the parent K99/R00 notice (opens in a new tab) owns the no-trial parent route.

Get research funding calls by email

About once a week, we email open research funding calls with a real deadline, from federal agencies such as NIH and NSF, picked for research institutions. One click to unsubscribe.

No spam. Unsubscribe anytime.

K99 Deadlines 2026 and 2027

The next parent K99 deadline is February 12, 2027 for new applications and March 12, 2027 for resubmissions. The last two 2026 dates, October 13 (new, moved from the Columbus Day holiday) and November 12 (resubmission), have passed. According to the Key Dates in PA-24-194 (opens in a new tab), checked November 15, 2026, K99 follows the K series standard dates: February 12, June 12 and October 12 for new applications, and March 12, July 12 and November 12 for renewals, resubmissions and revisions, due by 5:00 p.m. local time of the applicant organization. A date on a weekend or federal holiday moves to the next business day.

K99 routeNext new deadlineNext resubmission deadlineLater listed datesExpires
Parent K99/R00, no independent trial (PA-24-194 (opens in a new tab))Feb 12, 2027Mar 12, 2027NoneMay 8, 2027
Parent K99/R00, trial required (PA-24-193)Feb 12, 2027Mar 12, 2027NoneMay 8, 2027
NCI K99/R00, no trial (PAR-25-135 (opens in a new tab))Feb 17, 2027Feb 17, 2027 (same date)Jun 15, 2027; Oct 14, 2027Oct 15, 2027
KT1/R00 (replaces K99 and K22, NOT-OD-26-098 (opens in a new tab))Due dates on or after Oct 12, 2027Not yet postedNot yet postedNot yet posted

A February 12, 2027 K99 falls in NIH's Cycle I, with review in June or July, council in August or October and an earliest start in September or December 2027, according to NIH's standard due dates page (opens in a new tab). Every K due date across activity codes is in the NIH grant deadlines calendar.

The February/March 2027 cycle is the last one PA-24-194 lists, and what comes after it isn't settled. In NOT-OD-26-098, released August 12, 2026, NIH said it will consolidate individual K notices into parent notices by program type for due dates on or after October 12, 2027. The K99 and K22 move into a new KT1/R00 "NIH Career Transition to Research Independence Award," and active NOFOs using current K activity codes (other than K00, K12, K43 and K76) will be expired by July 13, 2027. That date comes before PAR-25-135's October 14, 2027 date, so NCI applicants aiming at October 2027 should confirm with NCI. The notice doesn't say whether a K99 route will take June 2027 applications. The same notice ends 'Independent Clinical Trial Required' K NOFOs and bars K funds from paying for a clinical trial. A postdoc who would hit the 4-year limit after February 2027 should treat February 12, 2027 as the safe date and check how the KT1/R00 notice defines eligibility once NIH posts it.

August 30, 2026 Grantsights Success-Rate Source Review

According to NIH PA-24-194, K99/R00 candidates must have no more than 4 years of counted postdoctoral research experience as of the relevant due date, and there is no citizenship requirement for K99 candidates. According to NIH, temporary visa status has to support the K99 and R00 phases at the applicant institutions. According to NCI notices, cancer researchers should check NCI's standalone K99/R00 route instead of assuming parent-program participation. PA-24-194 lists new-application dates of February 12, June 12 and October 12 and resubmission dates one month later; NIH moves a date that lands on a weekend or federal holiday to the next business day. With the October 2026 cycle closed, parent-route applicants should plan for February 12, 2027 (new) or March 12, 2027 (resubmission). PA-24-194 itself expires May 8, 2027. For rate claims, Grantsights reviewed the March 2026 NCI workshop chart and the NCI FY2007-FY2022 evaluation, then kept their source units separate. On October 8, 2026, Grantsights downloaded NIH Data Book table 204 and checked the K99 rows used above against it.

For most candidates, the decision is not "am I a good scientist?" It is whether the candidate clock, independence evidence, clinical-trial lane, institute participation, and mentor-overlap story all point to the same application. What official sources do not tell you is how quickly a technically eligible candidate can become a poor fit when the R00 aims still look like the mentor's project. For example, one applicant at a cancer center with strong papers should compare the NCI route first, while one behavioral-science postdoc with a prospective basic human study should check the BESH route before drafting aims. A third example is a postdoc with 47 months of counted experience, a first-author paper in press, and a February 2027 target date: that person has a deadline problem and a mentor-letter problem, not only an eligibility problem.

Decision checklist: apply if the candidate is still in a mentored postdoctoral role, needs at least 12 months of real training, has a portable R00 project, and can document protected effort. Skip or reroute if the candidate already acts as an independent PI, has a faculty-like appointment, needs R21 or R01 scale, or cannot separate the R00 work from the mentor's funded aims. If the project is already independent enough for a research grant, compare the NIH R01 hub, R01 success-rate analysis, and NIH resubmission guide before defaulting to a K99/R00 resubmission.

A red flag to check before drafting: does any R00 aim depend on a reagent, dataset, or method that belongs to the mentor's R01? If it does, a strong publication record won't rescue the independence argument. Rebuild that aim around something you can take with you, name a co-mentor if you need a method your primary mentor doesn't own, and use the Specific Aims guide so the independence claim is clear on the first page. PA-24-194 won't flag this problem for you.

Last updated: November 15, 2026

A common mistake is applying too late, at year 3.5 or 4 of a postdoc, when reviewers start asking whether you still need mentored training or whether you should just apply for faculty positions. The application looks strongest when you have clear training goals you genuinely haven't accomplished yet. If you're already doing independent research and managing your own lab members, reviewers will wonder why you need 2 more years of mentored support.

The second mistake: treating the career development plan as a formality. The CDP is not a list of courses you'll take. It's a detailed argument that specific gaps in your current skill set will be filled by a specific training program, and those skills are essential for your proposed research. Reviewers who score CDPs harshly are looking for one thing: evidence that you've actually thought through what independence requires and designed a plan to get there.


The Two-Phase Structure

K99 Phase: Mentored Postdoctoral Research (1-2 Years)

The K99 phase keeps you at your current postdoctoral institution under your mentor's supervision. The goal is not to do more of the same work, it's to complete the final phase of training while developing the skills and preliminary data you'll need as an independent investigator.

K99 PhaseStandard ProgramNCI Program (PAR-25-135)
Duration1-2 years1-2 years
Annual salary limitSet by institute: $75,000 + fringe at most institutes; $100,000 at NHLBI, NIAID, NIDA, NIDCR, NINR$100,000 + fringe
Annual research costsSet by institute, commonly $20,000 to $25,000Up to $30,000
Indirect cost rate8% of MTDC8% of MTDC
InstitutionMust stay at current postdoc institutionSame

PA-24-194 sets no single salary or research figure: it says both may be requested "to the level provided by the awarding Institute or Center." The NIH salary cap guide has the institute-by-institute K99 salary table, and NIH's career development funding considerations page (opens in a new tab) lists each institute's research support.

The 8% indirect cost rate for the K99 phase is unusually low: most grants pay the institution's negotiated rate (often 50-60% of modified total direct costs). The R00 phase switches to the new institution's negotiated rate, according to PA-24-194.

R00 Phase: Independent Research (Up to 3 Years)

The R00 phase activates at a new institution after you accept a tenure-track or equivalent faculty position. You must apply to activate the R00 at least 2 months before the proposed start date.

R00 PhaseAll Institutes
DurationUp to 3 years
Maximum annual support$249,000 total (salary + fringe + research + indirect)
Indirect costsInstitution's approved negotiated rate
EquipmentUp to $50,000 in R00 phase (NIGMS)
When activatedAfter accepting tenure-track or equivalent faculty position

The $249,000 annual cap is total costs, not direct costs. Your institution's indirect cost rate is applied to the direct cost portion. At an institution with a 55% F&A rate, $249,000 total costs translates to roughly $160,000 in direct costs per year for salary, fringe, and research.

The R00 is not renewable. Three years of independent support is what you get. The explicit goal is that you will have generated enough preliminary data by the end of the R00 to submit a competitive R01, and ideally have it funded before the R00 ends.


Eligibility Requirements

Standard Parent Program (PA-24-194)

  • Postdoctoral experience: No more than 4 years at time of application or resubmission
  • Position: Must be in a mentored, postdoctoral training role
  • Effort: Minimum 75% of full-time professional effort (9 calendar months)
  • Independence: Cannot hold, or have held, a faculty-level independent research position
  • Citizenship: None, open to US citizens, permanent residents, and international researchers

Only research time counts toward the 4 years. According to PA-24-194, leave of generally less than 12 months for personal, family, medical or military reasons is typically excluded, part-time research is pro-rated, and NIH approves a one-year extension for childbirth if the child's date of birth is provided at least 12 weeks before submission. Ask the institute about other extensions before you rely on one.

June 18 Planning Screen: When the K99/R00 Is the Wrong First Click

Use this screen before you open the application package. It keeps the K99/R00 guide from competing with exact NIH program pages and helps candidates pick the right NIH route.

Candidate signalBetter first clickWhy it matters
No independent clinical trial and still clearly mentoredParent K99/R00 no-trial pageThe no-trial notice owns eligibility, IC participation, due dates, and transition rules
Candidate will lead a clinical trialParent K99/R00 clinical-trial-required pageThe human-subjects and trial-leadership burden changes the application, and NOT-OD-26-098 retires trial-required K notices by July 13, 2027
Behavioral or social study with human participants but no clinical trialParent K99/R00 BESH pageBESH classification can change forms, review expectations, and study framing
Already has a junior faculty appointmentK01 route or K23 routeThe question may be protected mentored time, not a postdoc-to-faculty bridge
Ready for independent project fundingNIH R01 hub or Specific Aims guideReviewers may not believe the candidate still needs a K99 mentored phase

The practical test is whether an NIH reviewer can believe the candidate needs the K99 phase and can also believe the R00 work will leave the mentor's lab. Those two claims fight each other in weak applications. A strong application makes them fit together: the K99 phase closes a named skill gap, and the R00 phase launches work the candidate can own elsewhere.

NCI Program (PAR-25-135 and PAR-25-313, Effective January 2025)

NCI departed the parent K99/R00 program on December 31, 2024 (NOT-CA-25-021). NCI's current requirements differ in important ways:

RequirementParent ProgramNCI Program
Maximum postdoctoral experience4 years6 years
Overlap with mentor's grantsStandard rulesCan sit within the mentor's awards' scope, but no duplicated aims or text
Research costs (K99)Set by each institute, commonly $20,000-$25,000/yearUp to $30,000/year
Salary (K99)Set by each institute: $75,000/year at most institutes, $100,000 at fiveUp to $100,000/year
Participating institutes21+ institutesNCI only

The 6-year eligibility window at NCI is a genuine advantage for cancer researchers who spent longer in postdoctoral training before applying. If you're 4.5 years into a postdoc and researching a cancer-related topic, NCI's program may still be open to you when the parent program is not.

2026 Temporary Eligibility Extension (NOT-OD-26-021): Now Used Up

After the 2025 lapse in federal appropriations, NIH released NOT-OD-26-021 (opens in a new tab) on January 30, 2026 and corrected it with NOT-OD-26-042 (opens in a new tab) on March 4, 2026. Candidates whose final 48-month due date fell in September-November 2025 could submit through February/March 2026, and those whose final due date fell in January-March 2026 could submit through June/July 2026. NIH applied these extensions automatically. Every extended date has now passed, so the notice doesn't help anyone applying in 2027. Extensions for childbirth, family, or medical reasons still need documentation sent to the institute.


Which Institutes Participate

Parent K99/R00 (PA-24-194): 21+ institutes including: NEI, NHLBI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NIMHD, NLM, NCCIH

NCI: Uses separate announcements (PAR-25-135 and PAR-25-313 as of January 2025)

NIGMS contact first: NIGMS says applicants are "strongly encouraged to contact K99 NIGMS staff" at nigmsk99@nigms.nih.gov before preparing an application. NIGMS also caps its K99 phase at $125,000 a year in total costs ($75,000 salary plus fringe and $25,000 research support) and R00 equipment at $50,000. Skipping that first email is a common mistake: it's the cheapest way to learn whether NIGMS sees the project as within its mission.

Not all institutes accept K99 applications every cycle. Check the specific NOFO for your target institute's current participation and any institute-specific requirements beyond the parent announcement.


K99 to R00: The Conversion Data

The conversion rate from K99 to R00 is 78% overall in the eLife analysis (2,701 of 3,456 extramural K99s awarded from 2006 through 2021). But that 78% breaks down in a revealing way:

ScenarioK99-to-R00 Conversion Rate
Moving to a new institution for R0093.9%
Staying at the same institution for R0069.4%
Overall78%

The program was designed to promote mobility, moving to a new institution for your independent career is the expected path, and the data reflects that. If you're planning to stay at your postdoctoral institution for your faculty position, you should still be able to activate the R00, but you'll need explicit documentation that your research is genuinely independent from your mentor's program.


Career Outcomes: What Happens After K99/R00

An eLife analysis published in 2024 tracked outcomes for K99/R00 awardees from 2006 to 2022. The findings are instructive:

Institutional concentration: 54% of K99 awardees came from just 10% of institutions (256 total institutions produced K99 awardees). R00 awardees were more dispersed: 46% from 10% of institutions (357 institutions). This suggests the R00 phase is doing its job of distributing talent, but the K99 phase is highly concentrated at a small number of research powerhouses.

The HBCU gap: As of the 2024 eLife analysis, no K99 awardee had yet been at a Historically Black College or University, and only two K99 awardees had activated an R00 at one. If you're at an HBCU and pursuing a K99, you're in genuinely uncharted territory, talk directly with your target institute's program staff about application development support.

Early faculty aging researchers should also compare the Paul B. Beeson K76 guide before defaulting to K99/R00, K08, or K23. Beeson is a narrower aging-leadership route, so the candidate story and mentor plan need different proof.

Gender: Women made up about 40% of K99 awardees from 2006 to 2022 (1,395 of 3,474), according to the eLife analysis (opens in a new tab).


What Reviewers Score: The Five Review Components

Reviewers give each criterion its own score, but PA-24-194 says an application doesn't need to be strong in every category to be judged likely to have major impact. That said, a thin candidate record or an R00 plan that looks like the mentor's project is hard to offset. NIH also stopped using paylines from the January 2026 council round, so a score doesn't map to a fixed funding cutoff; ask your institute's program officer how it's making K99 decisions.

1. Candidate (Most Critical)

Reviewers assess your record as an independent thinker, not just a productive lab member. They want to see:

  • Career development trajectory: clear narrative from past training to current position to proposed K99 goals
  • Publication record: at least one strong first-author paper with your current postdoc mentor is expected; without it, reviewers will note the absence as a moderate weakness
  • Prior funding: F32, F99, internal institutional fellowships, all strengthen your record
  • Evidence that you think independently, not just execute your PI's ideas

What sinks applications here: If your record is so strong that reviewers ask "why does this person need more mentored training?" that's a different problem but a real one. The K99 should address a genuine training gap, not just provide salary while you pursue research you're already capable of doing independently.

2. Career Development Plan (CDP)

The CDP is not a course catalog. It's a targeted argument that specific skills you don't currently have will be provided by a specific training program, and those skills are essential for your independent research.

Strong CDPs include:

  • Explicit identification of skill gaps (methodology, grant writing, lab management, statistical approaches)
  • Named training activities that address each gap (specific courses, workshops, collaborations with named investigators)
  • Timeline with milestones
  • Plan for the transition to independence beyond just research activities (teaching, mentoring, leadership)

The CDP must be internally consistent with your mentor's letter. Reviewers read both documents. If your CDP says you'll complete a specific machine learning course and your mentor's letter doesn't mention it, that inconsistency raises questions about coordination.

3. Research Plan

The research plan covers both K99-phase and R00-phase work. Both phases need preliminary data in a strong application.

K99-phase aims: typically focus on completing final postdoctoral experiments and generating the data foundation for the R00 research program.

R00-phase aims: must be clearly independent from your mentor's research program. This is the single most important structural requirement. If your R00 aims could be funded as a sub-aim on your mentor's R01, reviewers will note the overlap as a critical weakness.

The R00 research plan should stand alone as an R01-scale scientific question. Reviewers are effectively pre-evaluating whether you'll have a fundable R01 at the end of the R00 period.

4. Mentor and Mentoring Plan

Your mentor must have:

  • Active independent extramural funding (R01 or equivalent)
  • A documented track record of trainees who went on to independent careers
  • A clear plan for your scientific independence, what research you'll take with you, what stays in their lab

The mentor's letter must explicitly address: how your R00 work will be independent from their ongoing research, what resources their lab provides during K99, and their commitment to your career independence (not just their lab's productivity).

A weak mentor can sink an otherwise strong application. If your primary mentor is junior or lacks a strong mentoring track record, co-mentors are essential.

5. Institution and Environment

Your department chair's letter should be personalized, not generic. It must confirm:

  • Your ability to commit 75% time to the K99 award
  • Institutional resources available to support your research
  • Commitment to your development and to your competing for, and moving into, a tenure-track assistant professor position (no faculty offer is required, and the K99 institution doesn't sponsor you during the R00 phase)
  • Visa support if applicable

A generic letter that could have been written about any postdoc signals that your department hasn't truly engaged with your career development.


When to Skip the K99 and Apply Directly for an R01

The K99/R00 is the right choice when you genuinely need 2 more years of mentored training and bridge funding before a faculty position. It's the wrong choice when you're ready for independence and the main benefit would be salary support.

Consider applying for an ESI R01 instead if:

  • You have 3+ strong first-author papers from your postdoc and are already getting faculty interview invitations
  • Your postdoctoral research is already sufficiently independent that the "mentored training" framing is hard to defend
  • Your target research question needs more research money than your institute's K99 research-support limit
  • You're within 6 months of accepting a faculty offer

Do not compare an R01 success rate with an institute-specific K99 success rate as if they were the same measure. The mechanisms use different applicant pools, review histories, budgets, and institute decisions. If you don't genuinely need the mentored phase, compare the project scope and career-stage rules with the NIH R01 hub before treating a K99 rate as the deciding factor.


What NIH's K99 Program Page Doesn't Tell You

The official K99/R00 program announcement (PA-24-194) tells you about eligibility windows, budget caps, and submission dates. What it doesn't tell you: that NCI quietly exited the parent program effective December 31, 2024 and cancer researchers now apply under a completely separate announcement; that the conversion rate from K99 to R00 drops from 93.9% to 69.4% if you stay at your postdoctoral institution instead of moving; that, as of the 2024 eLife analysis, no K99 awardee had yet been at an HBCU; or that applying at year 3.5-4 of your postdoc creates a credibility problem reviewers won't explicitly name but will score against you. It also doesn't tell you that the parent K99 has only the February/March 2027 cycle left under PA-24-194 before NIH's KT1/R00 switch.

Sources


Award data for this program

Frequently Asked Questions

What is the difference between the K99 and R00 phases?

The K99 phase is a 1-2 year mentored award that you complete at your current postdoctoral institution. Salary and research support are set by the funding institute: most allow $75,000 a year in salary plus fringe, while NHLBI, NIAID, NIDA, NIDCR and NINR allow $100,000. That support lets you finish final postdoc experiments, publish key papers, and develop skills for independent research. The R00 phase is a 3-year independent award that you activate at a new institution after accepting a tenure-track or equivalent faculty position. The R00 provides up to $249,000 total annual support (salary, fringe, research costs, and indirect costs), launching your independent research program and providing the preliminary data for your first R01.

Who is eligible for the K99/R00 award?

You must be in a mentored postdoctoral research position and have no more than 4 years of postdoctoral experience at the time of application (standard parent program, PA-24-194). NCI now uses a separate program (PAR-25-135) allowing up to 6 years of postdoctoral experience. There is no citizenship requirement for the K99/R00, it is open to US and international researchers. You must commit at least 75% of your full-time professional effort to the award. You cannot have held a faculty-level independent research position.

What is the success rate for the K99/R00?

NIH funded 19.5% of K99 applications in FY2025: 319 awards from 1,632 reviewed applications, according to NIH Data Book table 204. That's down from 25.0% in FY2024 and the lowest rate since FY2015, where the table starts. Rates differ a lot by institute, from 6.1% at NIMH to 32.3% at NIAID among institutes that reviewed 90 or more applications, so use your target institute's row.

What is the K99 acceptance rate?

NIH doesn't publish an acceptance rate separately; the figure people mean is the success rate, awards divided by reviewed applications. For the K99 it was 19.5% in FY2025 (319 of 1,632), 25.0% in FY2024 and 26.0% in FY2023, according to NIH Data Book table 204 (checked November 15, 2026). FY2026 figures aren't published yet.

When is the K99 deadline in 2026 and 2027?

The last 2026 parent K99 dates, October 13 (new, moved from the Columbus Day holiday) and November 12 (resubmission), have passed. The next are February 12, 2027 for new applications and March 12, 2027 for resubmissions under PA-24-194, due by 5:00 p.m. local time of the applicant organization. PA-24-194 expires May 8, 2027 and lists no later dates. NCI's PAR-25-135 is next due February 17, 2027 for new and resubmission applications.

What is PA-24-194?

PA-24-194 is NIH's parent K99/R00 Pathway to Independence Award for candidates who won't lead an independent clinical trial. It was posted April 24, 2024, allows up to 4 years of postdoctoral research experience, has no citizenship requirement, pays K99 indirect costs at 8% and caps the R00 phase at $249,000 a year in total costs. Its last due dates are February 12, 2027 (new) and March 12, 2027 (resubmission), and it expires May 8, 2027. NCI stopped taking applications through it in January 2025.

When is the best time to apply for a K99?

Optimal timing is year 2-3 of your postdoctoral training. You need enough publications to demonstrate independent research potential (at least one strong first-author paper from your current postdoc position is expected), and you need enough time remaining in your eligibility window to complete the 1-2 year K99 phase. Applying at year 3 is often the sweet spot, strong enough record to compete, enough time to complete training. If your publication record is already strong enough to get direct faculty offers, applying for an ESI R01 instead of K99 may provide more funding per year with no additional mentoring requirement.

Does NCI still offer the K99/R00 award?

Yes, but NCI left the parent K99/R00 program (PA-24-194) on December 31, 2024. NCI now uses its own announcements: PAR-25-135 (Clinical Trial Not Allowed) and PAR-25-313 (Clinical Trial Required). NCI's program differs from the parent: eligibility extends to 6 years of postdoctoral experience (vs. 4 years standard), and NCI says the K99 project can sit within the scope of the mentor's awards but can't duplicate their aims or text. Check cancer.gov for current NCI K99 requirements before applying.

Last updated November 15, 2026. Corrected November 15, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.